|
related topics |
{product, market, service} |
{customer, product, revenue} |
{property, intellectual, protect} |
{acquisition, growth, future} |
{product, candidate, development} |
{operation, international, foreign} |
{regulation, change, law} |
{personnel, key, retain} |
{tax, income, asset} |
{condition, economic, financial} |
{product, liability, claim} |
{stock, price, operating} |
{operation, natural, condition} |
|
Our success depends upon the continued emergence and growth of markets for analysis of genetic variation and biological function.
If the quality of our products does not meet our customers expectations, then our sales and operating earnings, and ultimately our reputation, could be negatively impacted.
If we do not successfully manage the development and launch of new products or services, including product transitions, our financial results could be adversely affected.
If we are unable to increase our manufacturing capacity and develop and maintain operation of our manufacturing capability, we may not be able to launch or support our products in a timely manner, or at all.
Our acquisitions expose us to risks that could adversely affect our business, and we may not achieve the anticipated benefits of acquisitions of businesses or technologies.
The timing and extent of funding provided by the American Recovery and Reinvestment Act of 2009 (the Recovery Act) could adversely affect our business, financial condition, or results of operations.
Unfavorable global economic conditions could adversely affect our business, financial condition, or results of operations.
Our continued growth is dependent on continuously developing and commercializing new products.
We depend on third-party manufacturers and suppliers for components and materials used in our products, and if shipments from these manufacturers or suppliers are delayed or interrupted, or if the quality of the components or materials supplied do not meet our requirements, we may not be able to launch, manufacture, or ship our products in a timely manner, or at all.
An inability to manage our growth or the expansion of our operations could adversely affect our business, financial condition, or results of operations.
If we lose our key personnel or are unable to attract and retain additional personnel, we may be unable to achieve our goals.
Doing business internationally creates operational and financial risks for our business.
We are subject to risks related to taxation in multiple jurisdictions and the possible loss of the tax deduction on our outstanding convertible notes.
Any inability to effectively protect our proprietary technologies could harm our competitive position.
Litigation, other proceedings, or third party claims of intellectual property infringement could require us to spend significant time and money and could prevent us from selling our products or services.
Our products, if used for the diagnosis of disease, could be subject to government regulation, and the regulatory approval and maintenance process for such products may be expensive, time-consuming, and uncertain both in timing and in outcome.
Our operating results may vary significantly from period to period, and we may not be able to sustain operating profitability.
Changes in accounting standards and subjective assumptions, estimates, and judgments by management related to complex accounting matters could significantly affect our financial results or financial condition.
Ethical, legal, and social concerns related to the use of genetic information could reduce demand for our products or services.
Full 10-K form ▸
|
|
related documents |
1060822--2/28/2007--CARTERS_INC |
917491--6/29/2006--FARO_TECHNOLOGIES_INC |
1014111--2/22/2007--IMATION_CORP |
851310--3/14/2006--HARMONIC_INC |
1001193--3/17/2008--TRANSMETA_CORP |
790818--3/18/2010--X_RITE_INC |
854398--12/13/2010--XATA_CORP_/MN/ |
717238--3/1/2007--MSC_SOFTWARE_CORP |
859014--6/13/2006--COMPUWARE_CORP |
355777--3/10/2006--LOJACK_CORP |
1289863--3/24/2009--SmartPros_Ltd. |
351012--8/11/2006--INTERMAGNETICS_GENERAL_CORP |
798736--7/18/2007--MANATRON_INC |
834306--3/16/2006--BIOSITE_INC |
1057083--3/16/2010--PC_TEL_INC |
785786--11/18/2008--PLEXUS_CORP |
1160858--5/1/2008--TRUE_RELIGION_APPAREL_INC |
64978--2/28/2007--MERCK_&_CO_INC |
103379--3/10/2006--V_F_CORP |
1025148--9/11/2006--MOBIUS_MANAGEMENT_SYSTEMS_INC |
1057083--3/16/2009--PC_TEL_INC |
1033905--3/16/2006--LUMINEX_CORP |
859014--5/30/2007--COMPUWARE_CORP |
1090872--12/22/2006--AGILENT_TECHNOLOGIES_INC |
873044--3/3/2006--RADISYS_CORP |
355777--3/13/2007--LOJACK_CORP |
717238--4/17/2006--MSC_SOFTWARE_CORP |
717238--6/12/2006--MSC_SOFTWARE_CORP |
1116521--12/8/2006--AVAYA_INC |
1341439--6/29/2009--ORACLE_CORP |
|